ADiTx Inc. announced that board members Jeffrey Runge and Saundra Pelletier will not stand for reelection at the 2025 Annual Meeting. Both will continue serving until their terms expire. Runge's departure is not due to any disagreement with the company. Pelletier, currently President and Executive Director of Evofem Biosciences, Inc., is expected to join the board and become President of Adifem after the merger between ADiTx and Evofem.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADiTx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-073670), on August 08, 2025, and is solely responsible for the information contained therein.